Biopterin metabolism in patients with malignant syndrome

Parkinsonism Relat Disord. 2003 Apr:9 Suppl 1:S11-4. doi: 10.1016/s1353-8020(02)00120-7.

Abstract

We examined the autopsied brains of two parkinsonian patients who had malignant syndrome (MS). Neopterin and biopterin contents, and GTP cyclohydrolase I activity were measured in various region of the brain. We found relatively higher GTP cyclohydrolase I activities in the hypothalamus compared with other regions of the brain from patients with MS. This finding suggested a possible involvement of biopterin metabolism in pathophysiology of MS. This is the first report on biopterin metabolism in the brains of patients with MS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antiparkinson Agents / adverse effects
  • Biopterins / metabolism*
  • Brain / metabolism*
  • Female
  • GTP Cyclohydrolase / metabolism
  • Humans
  • Male
  • Middle Aged
  • Neopterin / metabolism
  • Neuroleptic Malignant Syndrome / etiology
  • Neuroleptic Malignant Syndrome / metabolism*
  • Parkinson Disease / drug therapy
  • Parkinson Disease / metabolism*
  • Substance Withdrawal Syndrome / metabolism

Substances

  • Antiparkinson Agents
  • Biopterins
  • Neopterin
  • GTP Cyclohydrolase